Gemini Therapeutics Inc
Change company Symbol lookup
Select an option...
GMTX Gemini Therapeutics Inc
GEO Geo Group Inc
SAIC Science Applications International Corp
MUR Murphy Oil Corp
SPHD Invesco S&P 500® High Dividend Low Volatility ETF
CODI Compass Diversified Holdings
MDRRP Medalist Diversified Reit Inc
BRKL Brookline Bancorp Inc
KBH KB Home
UPS United Parcel Service Inc
Go

Health Care : Biotechnology |
Company profile

Gemini Therapeutics, Inc., formerly FS Development Corp., is a clinical-stage precision medicine company. The Company is principally focused on developing novel therapeutic compounds to treat genetically defined, age-related macular degeneration (AMD). The Company's lead product candidate, GEM103, is a recombinant form of the human complement factor H protein (CFH) and is designed to address both complement hyperactivity and restore retinal health in patients with AMD. Its Pipeline of product candidate includes (adeno-associated virus) AAV-CFH, AAV-CFI, AAV-Ab, GEM104 and GEM307. Its AAV-CFH program is complementary to GEM103 program, as AAV-CFH is a construct that express GEM103 continuously at a therapeutic level. The Company do not own or operate manufacturing facilities for the production of clinical or commercial quantities of its product candidates.

Closing Price
$1.75
Day's Change
-0.21 (-10.71%)
Bid
--
Ask
--
B/A Size
--
Day's High
2.00
Day's Low
1.68
Volume
(Light)
Volume:
170,522

10-day average volume:
216,340
170,522
  • Prev Close
    1.96
  • Today's Open
    1.97
  • Day's Range
    1.68-2.00
  • Avg Vol (10-day)
    216.3K
  • Last (time)
    4:00p ET 01/27/22
  • Last (size)
    5
  • 52-Wk Range
    1.66 - 19.09
    LowHigh
  • (03/15/21 - 01/24/22)
    5.42%
  • 87.3%
  • Market Cap
    75.4M
  • Shares Outstanding
    43.1M
  • -1.43
  • --
  • No dividend
  • Ex-dividend Date
    No dividend
  • Dividend Pay Date
    No dividend
  • --
  • 71.11
  • (% of float 12/31/21)
    6.57

Earnings Calendar and Events Data provided by |Terms of Use| © 2022 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

"Hot" indicates urgent and noteworthy news stories as determined by providers Dow Jones or Benzinga. TD Ameritrade does not select or recommend "hot" stories.

Information and news provided by ,, , Computrade Systems, Inc., ,, and

Copyright © 2022. All rights reserved.